Looking Ahead: A Brighter Future for immunocompromised Individuals
For adults living with HIV, the threat of pneumococcal disease - infections caused by the bacterium Streptococcus pneumoniae - is significantly higher. Traditionally, these individuals have faced a greater risk of contracting pneumonia, meningitis, and bloodstream infections. Now, a newly approved pneumococcal conjugate vaccine, V116, promises broader and more robust protection, offering a critical advancement in preventative care.